The results of a phase 1b study that evaluated a potential new treatment for macular edema associated with inflammation, ...
The trials are evaluating DURAVYU (vorolanib intravitreal insert) for the treatment of diabetic macular edema (DME).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results